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Poster Presentations: Tuesday, July 16, 2019P970of limited knowledge of brain membrane lipids. Therefore, we
studied glycerophospholipids (GP) and sphingolipids (SP) that
constitute the major lipid component of membranes and are precur-
sors of inflammatory or apoptotic molecules in CSF fractions. Re-
sults: GPs are differentially metabolized in nanoparticle (NP)
membrane and supernatant fluid (SF) fractions of cerebrospinal
fluid (CSF). Most GPs and molecular species from cognitively
healthy participants with pre-symptomatic AD, based on abnormal
CSF Aß42/Tau levels (CH-PAT, pre-symptomatic), were increased
compared to those of cognitively healthy with normal Aß42/Tau
(CH-NAT) and AD participants. Plasmalogen-containing phospha-
tidylethanolamine was decreased the most in AD and was the only
GP species that was reduced in CH-PAT compared with CH-NAT.
In SF, sphingomyelin (SM) decreased in CH-PAT and AD
compared with CH-NAT and this corresponded with an increase
in ceramide (CM) and dihydroceramide (dhCM). In contrast to
the SF fraction, there is an increase in SM in the NP fraction
from CH-PAT, decease in CM and dhCM, and an increase in the ra-
tio SM/CM. On investigating the mechanism for the lipid changes
in AD, we observed that phospholipase A2 (PLA2) activity
increased in AD, but not in the preclinical stages. Considering
external influences on lipids, the clinical groups did not differ in
their fasting blood lipids or intake of dietary lipids, consistent
with the CSF lipid changes originating from brain pathophysiology.
Conclusions: The lipid accumulation that we report in preclinical
AD identifies perturbation of lipid metabolism and disturbances
in APP/Aß as early events in AD pathophysiology. Our results iden-
tify increased lipid turnover in preclinical AD switching to a pre-
dominantly lipolytic state in dementia, knowledge that may be
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ease Neuroimaging Initiative (ADNI) to investigate and understand
dementia-related late-onset cognitive impairment using neuroi-
maging and genetics biomarkers. Methods: The 1,245 subjects im-
plemented using ADNI 1, ADNI GO and ADNI 2 were divided into
three groups: those with Alzheimer’s disease (AD), those with mild
cognitive impairment (MCI), and those in the normal control (NC)
group. Two hundred twenty eight of the subjects qualified for AD
diagnosis at the baseline; 684 had MCI; and 333 were included in
the NC group. The structural ADNI data were parcellated using
FreeSurfer metrics, and all the SNPs for the 1,245 subject were ex-
tracted using Plink and the Pipeline environment. Network analyses
were applied for all the subjects. Results: Our previous study for theAD,MCI and NC subjects (using ADNI 1 - 808 subjects), indicated
the significant associations between the SNPs and the neuroimaging
phenotypes for theAD,MCI andNC subjects. The previous findings
included that the set of 140 genes chosen (from 416 SNPs with p<
0.00005) represented commonly appearing genes in known AD
gene networks. Sowe expect that we can get moremeaningful result
from the 1,245 subjects implemented using ADNI 1, ADNI GO and
ADNI 2, because more big data have built up. Conclusions: We
expect the significant correlations between the SNPs and the neuro-
imaging phenotypes in the 1,245 subjects in terms of neuroimaging
genetics networking analyses. These analyses may explain some of
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Background: As various types of cognitive disorders present with
language dysfunctions, computational speech analysis methods
have been proposed aiming at detection of dementia and mild
cognitive impairment (MCI) at earlier stages. The speech analysis
is expected to be useful as a non-invasive, affordable screening
tool in daily lives. However, as previous studies have mostly inves-
tigated voices recorded in clinical interviews or laboratory settings,
little is known about the effectiveness of these methods for voices
recorded in realistic daily life situations.Methods: 158 participants
(80 males, 78 females), aged 56-88 years (mean¼73.1, SD¼7.6),
performed immediate verbal recall tasks on a commercially-avail-
able smartphone at home (33 in assisted living, 125 at normal
home). The participants included patients with dementia (n¼44)
and MCI (n¼63) as well as healthy controls (n¼51). The tasks
were presented among a series of cognitive exercises implemented
on a smartphone application. Speech analysis models exploited
acoustic, fluency, and lexical features. The ratio of successfully-re-
corded voice samples was also tested to examine if the participants
could perform the tasks without human instructions. Results: There
were significant differences in acoustic (e.g., jitter and shimmer)
and lexical (e.g., recall rate) features between MCI vs. control
and dementia vs. control (p<.01 for both). No significant differ-
ences were found in fluency features (e.g., pauses and hesitations).
The area under the ROC curve (AUC) of logistic regression models
were 0.857 for MCI vs. control, 0.612 for dementia vs. MCI, and
0.892 for dementia vs. control. The ratio of successfully-recorded
voice samples was 42.1%, 46.2%, and 90.0% for dementia, MCI,
and control, respectively. A logistic regression model based on
the same set of features could classify successfully-recorded and
useless voice samples with AUC of 0.894. Conclusions: The results
showed that the speech analysis can be effective for dementia and
MCI screening even when voices are recorded through a smart-
phone application in daily life situations. A computational model
could also be used to sort out voice samples to input to the screening
models, which implies a fully-automated personal screening appli-
cation can be built on a standard smartphone by combining the two
types of models.
